Tobira Therapeutics, Inc. Common Stock
TBRA
TBRA was delisted on the 31st of October, 2016.
47 hedge funds and large institutions have $5.9M invested in Tobira Therapeutics, Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 13 closing their positions.
0% more call options, than puts
Call options by funds: $4K | Put options by funds: $4K
7% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 14
4% less funds holding
Funds holding: 49 → 47 (-2)
15% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 13
91% less capital invested
Capital invested by funds: $64.6M → $5.9M (-$58.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.93M |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$1.23M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$269K |
| 4 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
+$222K |
| 5 |
SG Americas Securities
New York
|
+$90.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$15.4M |
| 2 |
PA
Perceptive Advisors
New York
|
-$5.84M |
| 3 |
VAM
Visium Asset Management
New York
|
-$4.07M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$2.72M |
| 5 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
-$1.22M |
TBRA Hedge Fund Activity: Q3 2014 in Review
47 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Tobira Therapeutics, Inc. Common Stock (TBRA) for Q3 2014, worth a combined $5.9M — down 91% from $64.6M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of TBRA and 11 opened new positions — a net loss of 2 holders — while 14 trimmed existing stakes and 13 added.
The largest buyer was Sabby Management, adding an estimated $1.93M. The largest seller was Gilder Gagnon Howe & Co, exiting entirely with an estimated $15.4M sold.
- 47 institutional investors held Tobira Therapeutics, Inc. Common Stock (TBRA) as of Q3 2014, down from 49 in Q2 2014.
- Funds reported $5.9M of Tobira Therapeutics, Inc. Common Stock stock for Q3 2014, down 91% quarter-over-quarter.
- 11 funds opened new Tobira Therapeutics, Inc. Common Stock positions in Q3 2014 and 13 closed out, a net change of -2 holders.
- The largest Tobira Therapeutics, Inc. Common Stock buyer in Q3 2014 was Sabby Management, an estimated $1.93M added.
- The largest Tobira Therapeutics, Inc. Common Stock seller in Q3 2014 was Gilder Gagnon Howe & Co, an estimated $15.4M sold.
Based on aggregated 13F filings for Q3 2014.